Literature DB >> 22576119

Effects of cryopreservation with polyethylene glycol on the expression of CD11b and CD62L on the surface of polymorphonuclear leukocytes.

M Feuerecker1, I Kaufmann, A P Salam, A Choukèr.   

Abstract

In experimental and clinical studies, expression of surface adhesion molecules such as ß2-integrine (CD11b) and L-selectin (CD62L) on polymorphonuclear leukocyte (PMNL) are investigated to assess certain crucial innate immune functions. Because the expression of CD11b and CD62L on PMNL can alter they cannot be quantified reliably when the time between blood draw and measurements is prolonged. Goals of this study were to test effects of cryopreservation on the expression of CD11b and CD62L on human PMNLs either under native conditions as well as after stimulation-dependant adhesion molecules´ expression pattern. CD11b and CD62L expression on PMNL can be cryopreserved with 10% of PEG-solution for at least one month at -60 degree C. This was observed in native, unstimulated as well as in stimulated cell-preparations. CD11b is very stable in contrast to CD62L expression which appears to be more susceptible to alteration due to freezing-thawing. However, the relative stimulus-dependant changes of activation can still be reflected.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576119

Source DB:  PubMed          Journal:  Cryo Letters        ISSN: 0143-2044            Impact factor:   1.066


  2 in total

1.  CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.

Authors:  Linda A Lieberman; Wanyong Zeng; Carol Singh; Wenting Wang; Kevin L Otipoby; Christine Loh; Tatiana Plavina; Leonid Gorelik; Richard M Ransohoff; Ellen Cahir-McFarland
Journal:  Neurology       Date:  2015-12-30       Impact factor: 9.910

2.  Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.

Authors:  Michela Spadaro; Marzia Caldano; Fabiana Marnetto; Alessandra Lugaresi; Antonio Bertolotto
Journal:  J Neuroinflammation       Date:  2015-08-12       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.